Clinical Study

A Multicenter, Randomized, Double-Blind, Parallel-Group Study To Assess The Efficacy And Safety Of Oral Etrasimod As Induction And Maintenance Therapy For Moderately To Severely Active Crohn’S Disease

Posted Date: Sep 21, 2021

  • Investigator: Loren Brook
  • Specialties:
  • Type of Study: Drug

This study is to evaluate the efficacy and safety of Etrasimod in subjects with moderate to severe Crohn's Disease.


Age 18-80. Diagnosis Of Crohn's Disease For At Least 3 Months Prior To Screening. Willing And Able To Comply With Procedures Required In The Protocol.


Crohn's, Crohn's Disease

For More Information:

Missy Randolph

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.